Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: Implications for cancer biology

Seminars in Cancer Biology

Volumn 18, Issue 3, 2008, Pages 199-210

  Stefano, George B ^a   Kream, Richard M ^a   Mantione, Kirk J ^a   Sheehan, Melinda ^a   Cadet, Patrick ^a   Zhu, Wei ^a   Bilfinger, Thomas V ^b   Esch, Tobias ^c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Department of Electrical Engineering and Computer Science   (Germany)

Author keywords

3 Opiate receptor; Cancer; Endogenous morphine; Nitric oxide; Stem cell

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; NITRIC OXIDE; OPIATE; TUMOR NECROSIS FACTOR ALPHA; TYRAMINE;

ANALGESIC ACTIVITY; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CELL FUNCTION; CELL PROLIFERATION; CHEMICAL ANALYSIS; CLINICAL STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG SYNTHESIS; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENCE; NEOPLASM; NONHUMAN; REVIEW; TUMOR GROWTH;

ANIMALS; BIOLOGY; CELL PHYSIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MORPHINE; NEOPLASMS; NITRIC OXIDE;

EID: 42649089753     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.12.003     Document Type: Review

References (158)

1. Merlin M.D. On the trail of ancient opium poppy (1984), Associated University Press, London
2. Stefano G.B., Fricchione G.L., Goumon Y., and Esch T. Pain, immunity, opiate and opioid compounds and health. Med Sci Monit 11 (2005) MS47-MS53
3. Zhu W., Mantione K.J., Shen L., Cadet P., Esch T., Goumon Y., et al. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit 11 (2005) BR397-BR404
4. Zhu W., Cadet P., Baggerman G., Mantione K.J., and Stefano G.B. Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol 175 (2005) 7357-7362
5. Olsen P., Rasmussen M., Stefano G.B., and Tonnesen E.K. Morphine affects the proliferation of tumour cells. Ugeskr Laeger 166 (2004) 4347-4350
6. Olsen P., Rasmussen M., Zhu W., Tonnesen E., and Stefano G.B. Human gliomas contain morphine. Med Sci Monit 11 (2005) MS18-MS21
7. Cadet P., Rasmussen M., Zhu W., Tonnesen E., Mantione K.J., and Stefano G.B. Endogenous morphinergic signaling and tumor growth. Front Biosci 9 (2004) 3176-3186
8. Kream R.M., and Stefano G.B. De novo biosynthesis of morphine in animal cells: an evidence-based model. Med Sci Monit 12 (2006) RA207-RA219
9. Stefano G.B., Goumon Y., Bilfinger T.V., Welters I., and Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 60 (2000) 513-530
10. Stefano G.B., Goumon Y., Casares F., Cadet P., Fricchione G.L., Rialas C., et al. Endogenous morphine. Trends Neurosci 9 (2000) 436-442
11. El Mouedden M., and Meert T.F. The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain. Pharmacol Biochem Behav 87 (2007) 30-40
12. Page G.G., Ben Eliyahu S., Yirmiya R., and Liebeskind J.C. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain 54 (1993) 21-28
13. Page G.G., Ben Eliyahu S., and Liebeskind J.C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immunol 8 (1994) 241-250
14. Page G.G., McDonald J.S., and Ben Eliyahu S. Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth 81 (1998) 216-223
15. Yeager M.P., and Colacchio T.A. Effect of morphine on growth of metastatic colon cancer in vivo. Arch Surg 126 (1991) 454-456
16. Hatzoglou A., Bakogeorgou E., and Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol 296 (1996) 199-207
17. Zagon I.S., McLaughlin P.J., Goodman S.R., and Rhodes R.E. Opioid receptors and endogenous opioids in diverse human and animal cancers. J Natl Cancer Inst 79 (1987) 1059-1065
18. Maneckjee R., and Minna J.D. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87 (1990) 3294-3298
19. Hatzoglou A., Ouafik L., Bakogeorgou E., Thermos K., and Castanas E. Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Res 55 (1995) 5632-5636
20. Bogden A.E., Taylor J.E., Moreau J.P., Coy D.H., and LePage D.J. Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline). Cancer Res 50 (1990) 4360-4365
21. Prevost G., Foehrle E., Thomas F., Pihan I., Veber N., Starzec A., et al. Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014. Endocrinology 129 (1991) 323-329
22. Setyono-Han B., Henkelman M.S., Foekens J.A., and Klijn G.M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res 47 (1987) 1566-1570
23. Cadet P., Bilfinger T.V., Fimiani C., Peter D., and Stefano G.B. Human vascular and cardiac endothelia express mu opiate receptor transcripts. Endothelium 7 (2000) 185-191
24. Cadet P., Mantione K.J., and Stefano G.B. Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 170 (2003) 5118-5123
25. Gupta K., Kshirsagar S., Chang L., Schwartz R., Law P.Y., Yee D., et al. Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62 (2002) 4491-4498
26. Singleton P.A., Lingen M.W., Fekete M.J., Garcia J.G., and Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 72 (2006) 3-11
27. Stefano G.B., and Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 4 (1994) 57-68
28. Stefano G.B. Autoimmunovascular regulation: morphine and anandamide stimulated nitric oxide release. J Neuroimmunol 83 (1998) 70-76
29. Stefano G.B., Leung M.K., Bilfinger T.V., and Scharrer B. Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules. J Neuroimmunol 63 (1995) 175-181
30. Magazine H.I., Chang J., Goumon Y., and Stefano G.B. Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis. J Immunol 165 (2000) 102-107
31. Provinciali M., Di Stefano G., Raffaeli W., Pari G., Desiderio F., and Fabris N. Evaluation of NK and LAK cell activities in neoplastic patients during treatment with morphine. Int J Neurosci 59 (1991) 127-133
32. Fuggetta M.P., Di F.P., Falchetti R., Cottarelli A., Rossi L., Tricarico M., et al. Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res 24 (2005) 255-263
33. Shavit Y., Ben-Eliyahu S., Zeidel A., and Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 11 (2004) 255-260
34. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 16 (1996) 109-144
35. Stefano G.B., Salzet B., and Fricchione G.L. Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol Today 19 (1998) 265-268
36. Payabvash S., Beheshtian A., Salmasi A.H., Kiumehr S., Ghahremani M.H., Tavangar S.M., et al. Chronic morphine treatment induces oxidant and apoptotic damage in the mice liver. Life Sci 79 (2006) 972-980
37. Maneckjee R., and Minna J.D. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 5 (1994) 1033-1040
38. Sueoka N., Sueoka E., Okabe S., and Fujiki H. Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression. Carcinogenesis 17 (1996) 2337-2341
39. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., and Jongeneel C.V. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171 (1990) 35-47
40. Esch T., and Stefano G.B. Proinflammation: a common denominator or initiator of different pathophysiological disease processes. Med Sci Monit 8 (2002) 1-9
41. Sueoka E., Sueoka N., Kai Y., Suganuma M., Kanematsu K., Yamamoto T., et al. Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappa B activation. Biochem Biophys Res Commun 252 (1998) 566-570
42. Jeremias I., Kupatt C., Baumann B., Herr I., Wirth T., and Debatin K.M. Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91 (1998) 4624-4631
43. Welters I.D., Fimiani C., Bilfinger T.V., and Stefano G.B. NF-kB, nitric oxide and opiate signaling. Med Hypotheses 54 (1999) 263-268
44. Welters I.D., Menzebach A., Goumon Y., Cadet P., Menges T., Hughes T.K., et al. Morphine inhibits NF-κB nuclear binding in human neutrophils and monocytes by a nitric oxide dependent mechanism. Anesthesiology 92 (2000) 1677-1684
45. Lord J.A.H., Waterfield A.A., Hughes J., and Kosterlitz H.W. Endogenous opioid peptodes: multiple agonists and receptors. Nature 267 (1977) 495-499
46. Gintzler A.R., Levy A., and Spector S. Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide morphine-like compound in the central nervous system. Proc Natl Acad Sci USA 73 (1976) 2132-2136
47. Gintzler A.R., Gershon M.D., and Spector S. A nonpeptide morphine-like compound: immunocytochemical localization in the mouse brain. Science 199 (1978) 447-448
48. Stefano G.B., Digenis A., Spector S., Leung M.K., Bilfinger T.V., Makman M.H., et al. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA 90 (1993) 11099-11103
49. Zhu W., Mantione K.J., Shen L., and Stefano G.B. In vivo and in vitro l-DOPA exposure increases ganglionic morphine levels. Med Sci Monit 11 (2005) MS1-MS5
50. Poeaknapo C., Schmidt J., Brandsch M., Drager B., and Zenk M.H. Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA 101 (2004) 14091-14096
51. Boettcher C., Fellermeier M., Boettcher C., Drager B., and Zenk M.H. How human neuroblastoma cells make morphine. Proc Natl Acad Sci USA 102 (2005) 8495-8500
52. Hiroi T., Imaoka S., and Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun 249 (1998) 838-843
53. Miller G.P., Hanna I.H., Nishimura Y., and Guengerich F.P. Oxidation of phenethylamine derivatives by cytochrome P450 2D6: the issue of substrate protonation in binding and catalysis. Biochemistry 40 (2001) 14215-14223
54. Guengerich F.P., Miller G.P., Hanna I.H., Sato H., and Martin M.V. Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps. J Biol Chem 277 (2002) 33711-33719
55. Niwa T., Hiroi T., Tsuzuki D., Yamamoto S., Narimatsu S., Fukuda T., et al. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Brain Res Mol Brain Res 129 (2004) 117-123
56. Esch T., Guarna M., Bianchi E., Zhu W., and Stefano G.B. Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Med Sci Monit 10 (2004) MS6-MS17
57. Stefano G.B., Zhu W., Cadet P., and Mantione K. Morphine enhances nitric oxide release in the mammalian gastrointestinal tract via the μ3 opiate receptor subtype: a hormonal role for endogenous morphine. J Physiol Pharmacol 55 (2004) 279-288
58. Donnerer J., Oka K., Brossi A., Rice K.C., and Spector S. Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci USA 83 (1986) 4566-4567
59. Lee S.C., and Spector S. Don't use changes in endogenous morphine and codeine contents in the fasting rat. J Pharmacol Exp Therapeut 257 (1991) 647-652
60. Epple A., Nibbio B., Spector S., and Brinn J. Endogenous codeine: autocrine regulator of catecholamine release from chromaffin cells. Life Sci 54 (1994) 695-702
61. Zhu W., Ma Y., Cadet P., Yu D., Bilfinger T.V., Bianchi E., et al. Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Mol Brain Res 117 (2003) 83-90
62. Goumon Y., Casares F., Zhu W., and Stefano G.B. The presence of morphine in ganglionic tissues of Modiolus deminissus: a highly sensitive method of quantitation for morphine and its derivatives. Mol Brain Res 86 (2001) 184-188
63. Zhu W., Baggerman G., Goumon Y., Casares F., Brownawell B., and Stefano G.B. Presence of morphine and morphine-6-glucuronide in the marine mollusk Mytilus edulis ganglia determined by GC/MS and Q-TOF-MS. Starvation increases opiate alkaloid levels. Brain Res Mol Brain Res 88 (2001) 155-160
64. Zhu W., Ma Y., and Stefano G.B. Presence of isoquinoline alkaloids in molluscan ganglia. Neuroendocrinol Lett 23 (2002) 329-334
65. Brix-Christensen V., Tonnesen E., Sanchez R.G., Bilfinger T.V., and Stefano G.B. Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?. Int J Cardiol 62 (1997) 191-197
66. Cadet P., Zhu W., Mantione K., Rymer M., Dardik I., Reisman S., et al. Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients. Int J Mol Med 12 (2003) 485-492
67. Stefano G.B., Zhu W., Cadet P., Mantione K., Bilfinger T.V., Bianchi E., et al. A hormonal role for endogenous opiate alkaloids: vascular tissues. Neuroendocrinol Lett 23 (2002) 21-26
68. Pasternak G.W. The opiate receptors (1988), Humana Press, New Jersey
69. Makman M.H., Bilfinger T.V., and Stefano G.B. Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 154 (1995) 1323-1330
70. Stefano G.B. The μ3 opiate receptor subtype. Pain forum 8 (1999) 206-209
71. Cruciani R.A., Dvorkin B., Klinger H.P., and Makman M.H. Presence in neuroblastoma cells of a μ3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res 667 (1994) 229-237
72. Makman M.H., Dvorkin B., and Stefano G.B. Murine macrophage cell lines contain μ3-opiate receptors. Eur J Pharmacol 273 (1995) R5-R6
73. Stefano G.B., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., et al. Presence of the mu3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J Biol Chem 270 (1995) 30290-30293
74. Dobrenis K., Makman M.H., and Stefano G.B. Occurrence of the opiate alkaloid-selective μ3 receptor in mammalian microglia, astrocytes and kupffer cells. Brain Res 686 (1995) 239-248
75. Stefano G.B., and Scharrer B. The presence of the μ3 opiate receptor in invertebrate neural tissues. Comp Biochem Physiol 113C (1996) 369-373
76. 3 opiate receptor subtype. Acta Pharmacol Sin 19 (1998) 403-407
77. Pasternak G.W. Multiple mu opiate receptors: biochemical and pharmacological evidence for multiplicity. Biochem Pharmacol 35 (1986) 361-364
78. Clark J.A., Liu L., Price M., Hersh B.S., Edelson M., and Pasternak G.W. Kappa opiate receptor multiplicity: evidence for two U50, 488-sensitive K1 subtypes and a novel K3 subtype. J Pharmacol Exp Ther 251 (1989) 461-468
79. Rothman R.B., Bykov V., DeCosta B.R., Jacobson A.E., Rice K.C., and Brady L.S. Interaction of endogenous opioid peptides and other drugs with four kappa binding sites in guinea pig brain. Peptides 11 (1990) 311-331
80. Mattia A., Farmer S.C., Takemori A.E., Sultana M., Portoghese P.S., Mosberg H.I., et al. Spinal opioid delta antinociception in the mouse mediation by a 5′-NTII-sensitive delta receptor subtype. J Pharmacol Exp Ther 260 (1992) 518-525
81. Stefano G.B., Melchiorri P., Negri L., Hughes T.K., and Scharrer B. (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci USA 89 (1992) 9316-9320
82. Traynor J.R., and Elliott J. δ-Opioid receptor subtypes and cross-talk with mu-receptors. Trends Pharmacol Sci 14 (1993) 84-86
83. Kieffer B.L., Befort K., Gaveriaux-Ruff C.E., and Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci, USA 89 (1992) 12048-12052
84. Evans C.J., Keith Jr. D.E., Morrison H., Magendzo K., and Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science 258 (1992) 1952-1955
85. Chen Y., Mestek A., Liu J., Hurley J.A., and Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 44 (1993) 8-12
86. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., et al. Cloning and functional comparison of k and δ-opioid receptors from mouse brain. Proc Natl Acad Sci, USA 90 (1993) 6736-6740
87. Stefano G.B., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 270 (1995) 30290-30293
88. Magazine H.I., Liu Y., Bilfinger T.V., Fricchione G.L., and Stefano G.B. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 156 (1996) 4845-4850
89. Liu Y., Shenouda D., Bilfinger T.V., Stefano M.L., Magazine H.I., and Stefano G.B. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res 722 (1996) 125-131
90. Sonetti D., Ottaviani E., and Stefano G.B. Opiate signaling regulates microglia activities in the invertebrate nervous system. Gen Pharmacol 29 (1997) 39-47
91. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ opioid receptor gene. Nature 383 (1996) 819-823
92. Cadet P., and Stefano G.B. Mytilus edulis pedal ganglia express μ opiate receptor transcripts exhibiting high sequence identity with human neuronal μ1. Mol Brain Res 74 (1999) 242-246
93. Ferreira S.H., Duarte I.D., and Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 201 (1991) 121
94. Przewlocki R., Machelska H., and Przewlocka B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci 53 (1993) PL1-PL5
95. Majeed N.H., Przewlocka B., Machelska H., and Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33 (1994) 189-192
96. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., and Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J Immunol 152 (1994) 5845-5851
97. Gyires K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur J Pharmacol 255 (1994) 33-37
98. Bilfinger T.V., Hartman A., Liu Y., Magazine H.I., and Stefano G.B. Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann Thorac Surg 63 (1997) 1063-1069
99. + current via guanylate cyclase in Aplysia neurons. J Neurosci Res 50 (1997) 450-456
100. Stefano G.B., Salzet B., Rialas C.M., Pope M., Kustka A., Neenan K., et al. Morphine and anandamide stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 763 (1997) 63-68
101. Bilfinger T.V., Fimiani C., and Stefano G.B. Morphine's immunoregulatory actions are not shared by fentanyl. Int J Cardiol 64 (1998) 61-66
102. Prevot V., Rialas C., Croix D., Salzet M., Dupouy J.-P., Puolain P., et al. Morphine and anandamide coupling to nitric oxide stimulated GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res 790 (1998) 236-244
103. Stefano G.B., Salzet M., and Bilfinger T.V. Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide. J Cardiovasc Pharmacol 31 (1998) 862-868
104. Stefano G.B., Salzet M., Magazine H.I., and Bilfinger T.V. Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 31 (1998) 813-820
105. Rasmussen M., Zhu W., Tonnesen J., Cadet P., Tonnesen E., and Stefano G.B. Effects of morphine on tumour growth. Neuroendocrinol Lett 23 (2002) 193-198
106. Tubaro E., Borelli G., Croce C., Cavallo G., and Santiangeli C. Effect of morphine on resistance to infection. J Infect Dis 148 (1983) 656-666
107. Weber R.J., Band L.C., DeCosta B., Pert A., and Rice K.C. Neural control of immune function: opioids, opioid receptors and immunosuppression. NIDA Res Monogr 105 (1991) 96-102
108. Perez-Castrillon J.P., Perez-Arellano J.P., Garcia-Palomo J.D., Jimenez-Lopez A., and DeCastro S. Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology 23 (1992) 57-61
109. Stefano G.B., and Bilfinger T.V. Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis. J Neuroimmunol 47 (1993) 189-198
110. Buga G.M., Wei L.H., Bauer P.M., Fukuto J.M., and Ignarro L.J. NG-hydroxy-l-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am J Physiol 275 (1998) R1256-R1264
111. Esch T., Stefano G.B., Fricchione G.L., and Benson H. Stress-related diseases: a potential role for nitric oxide. Med Sci Monit 8 (2002) RA103-RA118
112. 3 opiate receptor expression in lung ang lung carcinoma: ligand binding and coupling to nitric oxide release. Cancer Lett 146 (1999) 45-51
113. Welters I.D., Menzebach A., Goumon Y., Langefeld T.W., Teschemacher H., Hempelmann G., et al. Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J Neuroimmunol 111 (2000) 139-145
114. Singh R., Pervin S., Karimi A., Cederbaum S., and Chaudhuri G. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-l-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 60 (2000) 3305-3312
115. Chang C.I., Liao J.C., and Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61 (2001) 1100-1106
116. Mantione K.J., Cadet P., Zhu W., Kream R.M., Sheehan M., Fricchione G.L., et al. Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition. Addict Biol 13 (2008) 118-123
117. Zhu W., Ma Y., Bell A., Esch T., Guarna M., Bilfinger T.V., et al. Presence of morphine in rat amygdala: evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit 10 (2004) BR433-BR439
118. Pak T., Cadet P., Mantione K.J., and Stefano G.B. Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease. Med Sci Monit 11 (2005) BR357-BR366
119. Paris D., Quadros A., Patel N., DelleDonne A., Humphrey J., and Mullan M. Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur J Pharmacol 514 (2005) 1-15
120. Jiang L., Jha V., Dhanabal M., Sukhatme V.P., and Alper S.L. Intracellular Ca(2+) signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Am J Physiol Cell Physiol 280 (2001) C1140-C1150
121. Deininger M.H., Wybranietz W.A., Graepler F.T., Lauer U.M., Meyermann R., and Schluesener H.J. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J 17 (2003) 1267-1276
122. Shariftabrizi A., Nifli A.P., Ansari M., Saadat F., Ebrahimkhani M.R., Alizadeh N., et al. Matrix metalloproteinase 2 secretion in WEHI 164 fibrosarcoma cells is nitric oxide-related and modified by morphine. Eur J Pharmacol 530 (2006) 33-39
123. Gobert A.P., McGee D.J., Akhtar M., Mendz G.L., Newton J.C., Cheng Y., et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 98 (2001) 13844-13849
124. Nicotera P., Bonfoco E., and Brune B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv Neuroimmunol 5 (1995) 411-420
125. Xie K., Huang S., Dong Z., Gutman M., and Fidler I.J. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55 (1995) 3123-3131
126. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W., et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181 (1995) 1333-1343
127. Lejeune P., Lagadec P., Onier N., Pinard D., Ohshima H., and Jeannin J.F. Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152 (1994) 5077-5083
128. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., and Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19 (1998) 711-721
129. Kampa M., Hatzoglou A., Notas G., Niniraki M., Kouroumalis E., and Castanas E. Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells. Cell Death Differ 8 (2001) 943-952
130. Stefano G.B., Salzet M., Rialas C., Mattocks D.W., Fimiani C., and Bilfinger T.V. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: Endothelial implications. Int J Cardiol 64 (1998) S3-S13
131. Zamir N., Quirion R., and Segal M. Ontogeny and regional distribution of proenkephalin- and prodynorphin-derived peptides and opioid receptors in rat hippocampus. Neuroscience 15 (1985) 1025-1034
132. Leslie F.M., Chen Y., and Winzer-Serhan U.H. Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system. Can J Physiol Pharmacol 76 (1998) 284-293
133. Zhu Y., Hsu M.S., and Pintar J.E. Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci 18 (1998) 2538-2549
134. Ventura C., and Maioli M. Opioid peptide gene expression primes cardiogenesis in embryonal pluripotent stem cells. Circ Res 87 (2000) 189-194
135. Kim E., Clark A.L., Kiss A., Hahn J.W., Wesselschmidt R., Coscia C.J., et al. Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. J Biol Chem 281 (2006) 33749-33760
136. BioE Inc. Methods for directed differentiation of MLPC. Rev. 2 (2005)
137. Collins D.P. Isolation and characterization of umbilical cord blood-derived multipotent stem cells arising from an adherent CD45+/CD34+ cell subset. 4th Annual International Umbilical Cord Blood Transplantation Symposium (2006)
138. Forraz N., Baradez M.O., and McGuckin C.P. Characterization of the first umbilical cord blood multi-lineage progenitor cell line by high-definition microarray. 8th Annual Meeting of the International Tissue Engineering Society (2005)
139. Forraz N., Collins D.P., Baradez M.O., and McGuckin C.P. Characterization of the first human umbilical cord blood multi-lineage progenitor cell line. Tissue Models for Therapeutics (2005)
140. BioE Inc. Development of clonal cell lines with multi-lineage potential from human umbilical cord blood, methods of isolation, expansion, and differentiation. 3rd Annual Meeting of the International Society for Stem Cell Research (2005)
141. Goodwin H.S., Bicknese A.R., Chien S.N., Bogucki B.D., Quinn C.O., and Wall D.A. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7 (2001) 581-588
142. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., and Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 (2004) 1669-1675
143. Horowitz D., Callahan J.F., Pelus L.M., Fukuda S., and King A.G. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products. Int Immunopharmacol 2 (2002) 721-730
144. Rameshwar P., Poddar A., and Gascon P. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymphoma 28 (1997) 1-10
145. Broome C.S., Whetton A.D., and Miyan J.A. Neuropeptide control of bone marrow neutrophil production is mediated by both direct and indirect effects on CFU-GM. Br J Haematol 108 (2000) 140-150
146. Sharp B.M., Roy S., and Bidlack J.M. Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol 83 (1998) 45-56
147. Cadet P., Mantione K.J., Zhu W., Kream R.M., Sheehan M., and Stefano G.B. A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol 179 (2007) 5839-5844
148. Stefano G.B., and Kream R.M. Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). Int J Mol Med 20 (2007) 837-841
149. Mujoo K., Krumenacker J.S., Wada Y., and Murad F. Differential expression of nitric oxide signaling components in undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev 15 (2006) 779-787
150. Madhusoodanan K.S., and Murad F. NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 32 (2007) 681-694
151. Torroglosa A., Murillo-Carretero M., Romero-Grimaldi C., Matarredona E.R., Campos-Caro A., and Estrada C. Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway. Stem Cells 25 (2007) 88-97
152. Goumon Y., Weeks B.S., Cadet P., and Stefano G.B. Identification of morphine in the adrenal medullary chromaffin PC-12 cell line. Mol Brain Res 81 (2000) 177-180
153. Zhu W., Baggerman G., Goumon Y., Zenk M.H., and Stefano G.B. Identification of morphine and morphine-6-glucuronide in the adrenal medullary chromaffin PC-12 cell line by nano electrospray ionization double quadrupole orthogonal acceleration time of flight mass spectrometry. Eur J Mass Spect 7 (2001) 25-28
154. Poeaknapo C., Schmidt J., Brandsch M., Dräger B., and Zenk M.H. Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA 101 (2004) 14091-14096
155. Fricchione G.L., Cytryn L., Bilfinger T.V., and Stefano G.B. Cell behavior and signal molecule involvement in a case study of malignant histiocytosis: a negative model of morphine as an immunoregulator. Am J Hematol 56 (1997) 197-205
156. Zhu W., Mantione K.J., Casares F.M., Cadet P., Kim J.W., Bilfinger T.V., et al. Alcohol-, nicotine-, and cocaine-evoked release of morphine from invertebrate ganglia: model system for screening drugs of abuse. Med Sci Monit 12 (2006) BR155-BR161
157. Zhu W., Mantione K.J., Casares F.M., Sheehan M.H., Kream R.M., and Stefano G.B. Cholinergic regulation of endogenous morphine release from lobster nerve cord. Med Sci Monit 12 (2006) BR295-BR301
158. Zhu W., Mantione K., Kream R.M., and Stefano G.B. Alcohol-, nicotine-, and cocaine-evoked release of morphine from human white blood cells: substances of abuse actions converge on endogenous morphine release. Med Sci Monit 12 (2006) BR350-BR354